Endocrine Abstracts

Context: Recent studies showed a high prevalence of anxiety and depressive symptoms in patients with primary hyperaldosteronism (PA). A cross-sectional analysis suggested only minor improvement following adrenalectomy (ADX) and mineralocorticoidreceptor antagonist (MRA) therapy.Objective: Our aim was to determine the course of anxiety and depression in untreated patients.Design: We investigated 15 patients with PA at time of diagno...